Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 2,244 | 1,867 | 2,315 | 962 | 2,046 |
| Cost of Goods | 717 | 1,068 | 2,027 | 1,979 | 1,362 |
| Gross Profit | 1,527 | 799 | 288 | -1,017 | 684 |
| Operating Expenses | -4,464 | 3,104 | 5,540 | 8,379 | 10,954 |
| Operating Income | 6,708 | -2,237 | -5,225 | -8,417 | -9,908 |
| Interest Expense | 1,329 | 535 | 0 | 469 | 0 |
| Other Income | 776 | 45 | -491 | 0 | -380 |
| Pre-tax Income | 6,155 | -2,727 | -5,716 | -8,886 | -10,288 |
| Net Income Continuous | 6,155 | -2,727 | -5,716 | -8,886 | -10,288 |
| Net Income | $6,155 | $-2,727 | $-5,716 | $-8,886 | $-10,288 |
| EPS Basic Total Ops | 2.60 | -1.20 | -2.80 | -4.40 | -5.20 |
| EPS Basic Continuous Ops | 2.57 | -1.25 | -2.89 | -4.49 | -5.20 |
| EPS Diluted Total Ops | 2.60 | -1.20 | -2.80 | -4.40 | -5.20 |
| EPS Diluted Continuous Ops | 2.57 | -1.25 | -2.89 | -4.49 | -5.20 |
| EBITDA(a) | $5,460 | $-1,263 | $-4,189 | $-7,390 | $-8,984 |